BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

507 related articles for article (PubMed ID: 33809928)

  • 1. Utilization of Isoflavones in Soybeans for Women with Menopausal Syndrome: An Overview.
    Chen LR; Chen KH
    Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33809928
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of soy isoflavones in menopausal health: report of The North American Menopause Society/Wulf H. Utian Translational Science Symposium in Chicago, IL (October 2010).
    North American Menopause Society
    Menopause; 2011 Jul; 18(7):732-53. PubMed ID: 21685820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoflavone Supplements for Menopausal Women: A Systematic Review.
    Chen LR; Ko NY; Chen KH
    Nutrients; 2019 Nov; 11(11):. PubMed ID: 31689947
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Design and baseline characteristics of the soy phytoestrogens as replacement estrogen (SPARE) study--a clinical trial of the effects of soy isoflavones in menopausal women.
    Levis S; Strickman-Stein N; Doerge DR; Krischer J
    Contemp Clin Trials; 2010 Jul; 31(4):293-302. PubMed ID: 20230914
    [TBL] [Abstract][Full Text] [Related]  

  • 5. S-(-)equol producing status not associated with breast cancer risk among low isoflavone-consuming US postmenopausal women undergoing a physician-recommended breast biopsy.
    Virk-Baker MK; Barnes S; Krontiras H; Nagy TR
    Nutr Res; 2014 Feb; 34(2):116-25. PubMed ID: 24461312
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Soy foods, isoflavones, and the health of postmenopausal women.
    Messina M
    Am J Clin Nutr; 2014 Jul; 100 Suppl 1():423S-30S. PubMed ID: 24898224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Soy isoflavones versus placebo in the treatment of climacteric vasomotor symptoms: systematic review and meta-analysis.
    BolaƱos R; Del Castillo A; Francia J
    Menopause; 2010; 17(3):660-6. PubMed ID: 20464785
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Phytoestrogens for menopausal vasomotor symptoms.
    Lethaby A; Marjoribanks J; Kronenberg F; Roberts H; Eden J; Brown J
    Cochrane Database Syst Rev; 2013 Dec; 2013(12):CD001395. PubMed ID: 24323914
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dietary Soy Isoflavone: A Mechanistic Insight.
    Chadha R; Bhalla Y; Jain A; Chadha K; Karan M
    Nat Prod Commun; 2017 Apr; 12(4):627-634. PubMed ID: 30520611
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of equol-producing capacity and soy-isoflavone profiles of supplements on bone calcium retention in postmenopausal women: a randomized crossover trial.
    Pawlowski JW; Martin BR; McCabe GP; McCabe L; Jackson GS; Peacock M; Barnes S; Weaver CM
    Am J Clin Nutr; 2015 Sep; 102(3):695-703. PubMed ID: 26245807
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of soy isoflavones on menopausal neurovegetative symptoms.
    Colacurci N; Zarcone R; Borrelli A; De Franciscis P; Fortunato N; Cirillo M; Fornaro F
    Minerva Ginecol; 2004 Oct; 56(5):407-12. PubMed ID: 15531858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disposition of soy isoflavones in normal human breast tissue.
    Bolca S; Urpi-Sarda M; Blondeel P; Roche N; Vanhaecke L; Possemiers S; Al-Maharik N; Botting N; De Keukeleire D; Bracke M; Heyerick A; Manach C; Depypere H
    Am J Clin Nutr; 2010 Apr; 91(4):976-84. PubMed ID: 20164315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Extracted or synthesized soybean isoflavones reduce menopausal hot flash frequency and severity: systematic review and meta-analysis of randomized controlled trials.
    Taku K; Melby MK; Kronenberg F; Kurzer MS; Messina M
    Menopause; 2012 Jul; 19(7):776-90. PubMed ID: 22433977
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Randomized controlled trial of whole soy and isoflavone daidzein on menopausal symptoms in equol-producing Chinese postmenopausal women.
    Liu ZM; Ho SC; Woo J; Chen YM; Wong C
    Menopause; 2014 Jun; 21(6):653-60. PubMed ID: 24149925
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risks and benefits of dietary isoflavones for cancer.
    Andres S; Abraham K; Appel KE; Lampen A
    Crit Rev Toxicol; 2011 Jul; 41(6):463-506. PubMed ID: 21438720
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical studies of red clover (Trifolium pratense) dietary supplements in menopause: a literature review.
    Booth NL; Piersen CE; Banuvar S; Geller SE; Shulman LP; Farnsworth NR
    Menopause; 2006; 13(2):251-64. PubMed ID: 16645539
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of isoflavones in relieving vasomotor menopausal symptoms - A systematic review.
    Jacobs A; Wegewitz U; Sommerfeld C; Grossklaus R; Lampen A
    Mol Nutr Food Res; 2009 Sep; 53(9):1084-97. PubMed ID: 19653225
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Isoflavone supplements containing predominantly genistein reduce hot flash symptoms: a critical review of published studies.
    Williamson-Hughes PS; Flickinger BD; Messina MJ; Empie MW
    Menopause; 2006; 13(5):831-9. PubMed ID: 16932241
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Soy isoflavones as safe functional ingredients.
    Song WO; Chun OK; Hwang I; Shin HS; Kim BG; Kim KS; Lee SY; Shin D; Lee SG
    J Med Food; 2007 Dec; 10(4):571-80. PubMed ID: 18158825
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of dose, frequency of administration, and equol production on efficacy of isoflavones for menopausal hot flashes: a pilot randomized trial.
    Crawford SL; Jackson EA; Churchill L; Lampe JW; Leung K; Ockene JK
    Menopause; 2013 Sep; 20(9):936-45. PubMed ID: 23511704
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.